Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants: A case report

Pharmacopsychiatry

Volumn 39, Issue 3, 2006, Pages 114-

  Yoshida, Keizo ^a   Sugawara, Y ^b   Higuchi, H ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Omagari City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CABERGOLINE; FLUVOXAMINE; IMIPRAMINE; MILNACIPRAN; SELEGILINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; NEUROTOXICITY; PRIORITY JOURNAL; REMISSION;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERGOLINES; FEMALE; FLUVOXAMINE; HUMANS; IMIPRAMINE; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 33745121541     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-946609     Document Type: Article

References (5)

1. Estebe JP, Myers RR. Amitriptyline neurotoxicity: dose-related pathology after topical application to rat sciatic nerve. Anesthesiology 2004; 100: 1519-1525
2. Gerner P, Mujtaba M, Khan M, Sudoh Y, Vlassalov K, Anthony DC et al. N-phenylethyl amitriptyline in rat sciatic nerve blockade. Anesthesiology 2002; 96: 1435-1442
3. Müller MJ, Himmerich H, Kienzle B, Szegedi A. Differentiating moderate and severe depression using the Montgomery-Åsberg depression rating scale (MADRS). J Affect Disord 2003; 77: 255-260
4. Perry PJ, Pfohl BM. The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis. Clin Pharmacokinet 1987; 13: 381-392
5. Thase ME. Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence. CNS Spectr 2004; 9: 808-816, 818-821